Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
2.

Viral evasion of NK-cell activation.

Rajagopalan S, Long EO.

Trends Immunol. 2005 Aug;26(8):403-5.

PMID:
15979408
3.

NKp30-dependent cytolysis of filovirus-infected human dendritic cells.

Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, Aman MJ, Bavari S.

Cell Microbiol. 2007 Apr;9(4):962-76.

PMID:
17381429
4.

Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

Byrd A, Hoffmann SC, Jarahian M, Momburg F, Watzl C.

PLoS One. 2007 Dec 19;2(12):e1339.

5.

NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.

Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR.

Ann N Y Acad Sci. 2007 Aug;1109:47-57.

PMID:
17785290
6.
7.

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.

Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, Moretta L, Moretta A, Vitale M.

Blood. 2006 Dec 15;108(13):4118-25. Epub 2006 Aug 10.

8.

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.

Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr.

FEBS Lett. 2007 Apr 3;581(7):1317-22. Epub 2007 Mar 1.

9.

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Böll B, Simhadri VL, Borchmann P, McKinnon PJ, Hallek M, Engert A.

Immunity. 2007 Dec;27(6):965-74. Epub 2007 Dec 6.

10.

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT.

Blood. 2007 Jan 1;109(1):323-30. Epub 2006 Aug 29.

11.

Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages.

Chevillotte M, Landwehr S, Linta L, Frascaroli G, Lüske A, Buser C, Mertens T, von Einem J.

J Virol. 2009 Mar;83(6):2480-90. doi: 10.1128/JVI.01818-08. Epub 2008 Dec 30.

12.

Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

Chalupny NJ, Rein-Weston A, Dosch S, Cosman D.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):175-81. Epub 2006 May 24.

PMID:
16750166
14.

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P, Congia S, Mingari MC, Moretta L.

Eur J Immunol. 2007 Feb;37(2):445-55.

15.
16.

A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells.

Mavoungou E, Held J, Mewono L, Kremsner PG.

J Infect Dis. 2007 May 15;195(10):1521-31. Epub 2007 Apr 3.

PMID:
17436233
17.

Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.

von Lilienfeld-Toal M, Nattermann J, Feldmann G, Sievers E, Frank S, Strehl J, Schmidt-Wolf IG.

Clin Exp Immunol. 2006 Jun;144(3):528-33.

18.

NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli.

Hollyoake M, Campbell RD, Aguado B.

Mol Biol Evol. 2005 Aug;22(8):1661-72. Epub 2005 May 4.

PMID:
15872155
19.

Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

Welte S, Kuttruff S, Waldhauer I, Steinle A.

Nat Immunol. 2006 Dec;7(12):1334-42. Epub 2006 Oct 22.

PMID:
17057721
20.

A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.

Binici J, Hartmann J, Herrmann J, Schreiber C, Beyer S, Güler G, Vogel V, Tumulka F, Abele R, Mäntele W, Koch J.

J Biol Chem. 2013 Nov 29;288(48):34295-303. doi: 10.1074/jbc.M113.483602. Epub 2013 Oct 16.

Supplemental Content

Support Center